Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas.
Peereboom DM, Supko JG, Carson KA, Batchelor T, Phuphanich S, Lesser G, Mikkelsen T, Fisher J, Desideri S, He X, Grossman SA; New Approaches to Brain Tumor Therapy (NABTT) Consortium. Peereboom DM, et al. Among authors: carson ka. J Neurooncol. 2010 Nov;100(2):261-8. doi: 10.1007/s11060-010-0190-0. Epub 2010 May 7. J Neurooncol. 2010. PMID: 20449631 Free PMC article. Clinical Trial.
Initial response to glucocorticoids.
Mathew BS, Carson KA, Grossman SA. Mathew BS, et al. Among authors: carson ka. Cancer. 2006 Jan 15;106(2):383-7. doi: 10.1002/cncr.21583. Cancer. 2006. PMID: 16342251 Free article.
Phase I and pharmacokinetic study of karenitecin in patients with recurrent malignant gliomas.
Grossman SA, Carson KA, Phuphanich S, Batchelor T, Peereboom D, Nabors LB, Lesser G, Hausheer F, Supko JG; New Approaches to Brain Tumor Therapy CNS Consortium. Grossman SA, et al. Among authors: carson ka. Neuro Oncol. 2008 Aug;10(4):608-16. doi: 10.1215/15228517-2008-030. Epub 2008 Jun 24. Neuro Oncol. 2008. PMID: 18577560 Free PMC article. Clinical Trial.
Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-alpha delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas.
Grossman SA, Alavi JB, Supko JG, Carson KA, Priet R, Dorr FA, Grundy JS, Holmlund JT. Grossman SA, et al. Among authors: carson ka. Neuro Oncol. 2005 Jan;7(1):32-40. doi: 10.1215/S1152851703000353. Neuro Oncol. 2005. PMID: 15701280 Free PMC article. Clinical Trial.
220 results